pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
HG-CT-1
Refractory Acute Myeloid Leukemia
HemoGenyx Pharmaceuticals Plc
0
catalysts
Phase 1
HL-5101
Solid Tumor
AUM Biosciences Pte Ltd
0
catalysts
Phase 2
HLD-0915
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Halda Therapeutics LLC
0
catalysts
Phase 1
HLTX-001
← prev
page 21 of 62
next →
131
Pain
89
Neurology
1
Neuroblastoma
Hula Therapeutics Inc
0
catalysts
Phase 1
HM-16390
Colorectal Cancer
Hanmi Pharmaceuticals Co Ltd
0
catalysts
Phase 2
HMBD-002
Dedifferentiated Liposarcoma
Percheron Therapeutics Ltd
0
catalysts
Phase 2
HMPLA-251
Solid Tumor
$HCM
HUTCHMED (China) Ltd
0
catalysts
Phase 2
HMPLA-580
Solid Tumor
$HCM
HUTCHMED (China) Ltd
0
catalysts
Preclinical
HND-034
Lung Cancer
Handa Pharmaceuticals LLC
0
catalysts
Preclinical
HND-039
Kidney Cancer (Renal Cell Cancer)
Handa Pharmaceuticals LLC
0
catalysts
Preclinical
HND-042
Unspecified Cancer
Handa Pharmaceuticals LLC
0
catalysts
Phase 1
HNSCC
Hypopharyngeal Cancer
Metaclipse Therapeutics Corp
0
catalysts
Preclinical
HP-520
Hinova Pharmaceuticals Inc
0
catalysts
Phase 2
HPV Induced Cancers
Cervical Cancer
Theravectys SA
0
catalysts
Phase 2
HST-1011
Anal Cancer
HotSpot Therapeutics Inc
0
catalysts
Preclinical
HT-KIT
Anaphylaxis
$HOTH
Hoth Therapeutics, Inc.
0
catalysts
Phase 1
HWK-007
Endometrial Cancer
$WHWK
Whitehawk Therapeutics, Inc.
0
catalysts
Phase 1
HWK-016
Endometrial Cancer
$WHWK
Whitehawk Therapeutics, Inc.
0
catalysts
Preclinical
HWK-206
Neuroendocrine Tumors
$WHWK
Whitehawk Therapeutics, Inc.
0
catalysts
Preclinical
Half-Life Extended BiTE
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$AMGN
AMGEN INC
0
catalysts
Phase 1
Hemay-181
Colon Cancer
Ganzhou Hemei Pharmaceutical Co Ltd
0
catalysts
Phase 2
IAE-0972
Cutaneous Squamous Cell Carcinoma (cSCC)
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 1
IAM-1363
Bladder Cancer
Iambic Therapeutics Inc
0
catalysts
Phase 2
IAP-0971
Cervical Cancer
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 2
IBB-0979
Solid Tumor
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 1
IBI-3020
Colon Cancer
Innovent Biologics Inc
0
catalysts
Phase 2
IBI-363
Metastatic Melanoma
Innovent Biologics Inc
0
catalysts
Preclinical
IBIO-101
Solid Tumor
$IBIO
iBio, Inc.
0
catalysts
Phase 1
IBRX-042
Head And Neck Cancer
$IBRX
ImmunityBio, Inc.
0
catalysts
Phase 1
ICG-122
T-Cell Leukemia
iCell Gene Therapeutics LLC
0
catalysts
